432 related articles for article (PubMed ID: 11884237)
21. Acute and delayed effects of fenthion in young chicks.
Farage-Elawar M; Francis BM
J Toxicol Environ Health; 1987; 21(4):455-69. PubMed ID: 2439699
[TBL] [Abstract][Full Text] [Related]
22. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
Kropp TJ; Richardson RJ
J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540
[TBL] [Abstract][Full Text] [Related]
23. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
Milatovic D; Moretto A; Osman KA; Lotti M
Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
[TBL] [Abstract][Full Text] [Related]
24. Effects of multiple dosing of fenthion, fenitrothion, and desbromoleptophos in young chicks.
Farage-Elawar M; Francis BM
J Toxicol Environ Health; 1988; 23(2):217-28. PubMed ID: 2449534
[TBL] [Abstract][Full Text] [Related]
25. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
26. NTE: one target protein for different toxic syndromes with distinct mechanisms?
Glynn P
Bioessays; 2003 Aug; 25(8):742-5. PubMed ID: 12879443
[TBL] [Abstract][Full Text] [Related]
27. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants.
Quistad GB; Klintenberg R; Casida JE
Toxicol Sci; 2005 Aug; 86(2):291-9. PubMed ID: 15888665
[TBL] [Abstract][Full Text] [Related]
28. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.
Makhaeva GF; Rudakova EV; Hein ND; Serebryakova OG; Kovaleva NV; Boltneva NP; Fink JK; Richardson RJ
J Appl Toxicol; 2014 Dec; 34(12):1426-35. PubMed ID: 24395470
[TBL] [Abstract][Full Text] [Related]
29. Interactions in vitro of some organophosphoramidates with neuropathy target esterase and acetylcholinesterase of hen brain.
Jokanovic M; Johnson MK
J Biochem Toxicol; 1993 Mar; 8(1):19-31. PubMed ID: 8492300
[TBL] [Abstract][Full Text] [Related]
30. [Early manifestations and mechanism of the neurotoxic action of organophosphorus pesticides].
Kagan IuS; Kokshareva NV; Tkachenko II
Biull Eksp Biol Med; 1986 Sep; 102(9):310-2. PubMed ID: 3019451
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro study of the inhibition of human and hen esterases by methamidophos enantiomers.
Emerick GL; DeOliveira GH; Oliveira RV; Ehrich M
Toxicology; 2012 Feb; 292(2-3):145-50. PubMed ID: 22198100
[TBL] [Abstract][Full Text] [Related]
32. Species susceptibility to delayed toxic neuropathy in relation to in vivo inhibition of neurotoxic esterase by neurotoxic organophosphorus esters.
Soliman SA; Linder R; Farmer J; Curley A
J Toxicol Environ Health; 1982 Feb; 9(2):189-97. PubMed ID: 7077681
[TBL] [Abstract][Full Text] [Related]
33. Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate.
Carrington CD; Abou-Donia MB
J Toxicol Environ Health; 1988; 25(3):259-68. PubMed ID: 3184197
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants.
Vose SC; Holland NT; Eskenazi B; Casida JE
Toxicol Appl Pharmacol; 2007 Oct; 224(1):98-104. PubMed ID: 17663017
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors.
Ehrich M; Jortner BS; Padilla S
Fundam Appl Toxicol; 1995 Jan; 24(1):94-101. PubMed ID: 7713347
[TBL] [Abstract][Full Text] [Related]
36. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
37. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s).
Suzuki H; Ito Y; Noro Y; Koketsu M; Kamijima M; Tomizawa M
Toxicol Lett; 2014 Feb; 225(1):153-7. PubMed ID: 24361246
[TBL] [Abstract][Full Text] [Related]
38. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
Chemnitius JM; Zech R
Mol Pharmacol; 1983 May; 23(3):717-23. PubMed ID: 6865914
[TBL] [Abstract][Full Text] [Related]
40. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
